Currently the price is 76,01$, Turning Point Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Athena Countouriotis (President, Chief Executive Officer & Director), Kumar Srinivasan (Chief Business Officer), Miriam Cruz (Vice President-Clinical Operations), Mohammad Hirmand (Chief Medical Officer & Executive Vice President), Paolo Tombesi (Executive VP, Chief Financial & Accounting Officer), Siegfried Reich (Chief Scientific Officer & Executive VP) and its address is 10628 SCIENCE CENTER DRIVE SUITE 200, SAN DIEGO, California, 92121, United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 76,00$ moving between 75,98$ and 76,01$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
